Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease

计划入组 8 人 · 首次发布于 2005 年 9 月 20 日

Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

计划入组 11 人 · 首次发布于 2011 年 12 月 5 日

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

计划入组 14 人 · 首次发布于 2011 年 11 月 21 日

Graft-versus-host disease therapeutics (Mallinckrodt)

Graft-versus-host disease therapy(Applied StemCell, Inc.)

Graft vs. Host Disease(Aegle)

Theriva Biologics

United States

InspireMD

Vascular Graft Solutions Ltd.

Israel

ReAlta Reports Promising Phase 2 Results for Pegtarazimod in Steroid-Refractory Acute Graft-Versus-Host Disease

hUC-MSCs Show Promise in Treating Steroid-Refractory Acute Graft-versus-Host Disease

Mesoblast Receives FDA Approval for First MSC Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease